Active Awards Portfolio Dashboard
It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards
Disease | Cell Type |
Therapeutic or Technology![]() |
Institution | Stage | Project Objective | Details |
---|---|---|---|---|---|---|
Leukemia, Acute Myeloid (AML) | Embryonic Stem Cell | Donor cell therapy | UCSD |
![]() |
Pre-IND/IDE or Equivalent | |
Age-related macular degeneration | Adult Stem Cell | Donor cell therapy | Stanford |
![]() |
Pre-IND/IDE or Equivalent | |
B cell cancers, Leukemia, Leukemia, Acute Myeloid (AML) |
Adult Stem Cell | Donor cell therapy | Stanford |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Kidney Failure | Adult Stem Cell | Donor cell therapy | Medeor Therapeutics |
![]() |
Clinical Trial, Phase 3 | |
Spinal Cord Injury | iPS Cell | Donor cell therapy | Stanford |
![]() |
Development Candidate, Proof of Concept | |
Huntington's Disease | Embryonic Stem Cell | Donor cell therapy | UC Irvine |
![]() |
IND | |
Stroke | Embryonic Stem Cell | Donor cell therapy | Stanford |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Pulmonary Hypertension, Vascular Disease |
Adult Stem Cell | Donor cell therapy | Cedars-Sinai |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Cartilage defect | Embryonic Stem Cell | Donor cell therapy | USC |
![]() |
IND | |
Sickle Cell Disease | Adult Stem Cell | Donor cell therapy | COH |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Kidney Failure | Adult Stem Cell | Donor cell therapy | Stanford |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Spina Bifida | Adult Stem Cell | Donor cell therapy | UC Davis |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Retinitis Pigmentosa | Other | Donor cell therapy | jCyte |
![]() |
Clinical Trial, Phase 2 | |
Heart failure | Embryonic Stem Cell | Donor cell therapy | Stanford |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Kidney Failure | Adult Stem Cell | Donor cell therapy | Stanford |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Heart Disease | iPS Cell | Donor cell therapy | UC Davis |
![]() |
Development Candidate, Proof of Concept | |
Stroke | iPS Cell | Donor cell therapy | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
Inflammatory bowel disease | Adult Stem Cell | Donor cell therapy | Vitabolus, Inc. |
![]() |
Development Candidate, Proof of Concept | |
Type 1 diabetes | Adult Stem Cell | Donor cell therapy | UCSF |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Traumatic Brain Injury | iPS Cell | Donor cell therapy | UC Irvine |
![]() |
Development Candidate, Research Insights | |
Alpha Thalassemia Major | Adult Stem Cell | Donor cell therapy | UCSF |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Retinitis Pigmentosa | Embryonic Stem Cell | Donor cell therapy | UC Irvine |
![]() |
Pre-IND/IDE or Equivalent | |
COVID-19 | Adult Stem Cell | Donor cell therapy | UCSF |
![]() |
Clinical Trial, Phase 2 | |
Cartilage defect, Osteoarthritis |
Embryonic Stem Cell | Donor cell therapy | Scripps Health |
![]() |
Development Candidate, Proof of Concept | |
Epilepsy | Embryonic Stem Cell | Donor cell therapy | Neurona Therapeutics |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Type 1 diabetes | Embryonic Stem Cell | Donor cell therapy | ViaCyte |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Traumatic Brain Injury | Embryonic Stem Cell | Donor cell therapy | UC Irvine |
![]() |
Pre-IND/IDE or Equivalent | |
COVID-19, Respiratory Disorders |
Adult Stem Cell | Donor cell therapy | Celularity Inc |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Spinal Cord Injury | Embryonic Stem Cell | Donor cell therapy | UCSD |
![]() |
Pre-IND/IDE or Equivalent | |
Liver Disease | iPS Cell | Diagnostic Test | UCSF |
![]() |
Development Candidate, Proof of Concept | |
Beta Thalassemia, Sickle Cell Disease |
Adult Stem Cell | Diagnostic Test | UCSF |
![]() |
Regulated Lab Test, Ready for Validation | |
Kidney Failure | Adult Stem Cell | Device | UC Davis |
![]() |
Pre-IND/IDE or Equivalent | |
COVID-19, Respiratory Disorders |
Other, Vital Research Opportunity |
Convalescent Plasma | COH |
![]() |
Research Insights | |
Embryonic Stem Cell | Cell processing & handling | Stanford |
![]() |
Research Insights | ||
Vascular Disease | Adult Stem Cell | Biologic | UCSD |
![]() |
Pre-IND/IDE or Equivalent | |
Cartilage defect | Adult Stem Cell | Biologic | The Stone Research Foundation for Sports Medicine and Arthritis |
![]() |
Development Candidate, Proof of Concept | |
Type 1 diabetes | iPS Cell | Biologic | UCLA |
![]() |
Development Candidate, Proof of Concept | |
Age-related macular degeneration | Embryonic Stem Cell | Biologic | USC |
![]() |
Pre-IND/IDE or Equivalent | |
Leukemia, Acute Myeloid (AML) | Cancer Stem Cell | Antibody | Immune-Onc Therapeutics |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Severe Combined Immunodeficiency, X-linked (X-SCID) | Adult Stem Cell | Antibody | Jasper Therapeutics, Inc. |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Heart Disease | Adult Stem Cell | Antibody | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
B cell cancers, Leukemia |
Cancer Stem Cell | Antibody | UCSD |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
UCLA | ||||||
UCSD | ||||||
UCLA | ||||||
UC Davis | ||||||
Scripps | ||||||
Cedars-Sinai | ||||||
UCSD | ||||||
UCLA |